Mumbai’s air quality has been rated as “Very Poor” with an AQI of 306 on Friday, according to the System of Air Quality and Weather Forecast and Research (SAFAR). Several areas in the city have recorded even hazardous AQI levels, with Mazagaon in south Mumbai at 358, Chembur at 343, and Malad, BKC, and Andheri at 311. The Mumbai air pollution crisis will continue for a few days ahead with no climate respite to disperse the pollution levels.
Other areas such as Colaba, Bhandup, Worli, and Borivali also recorded AQI in the “Poor” to “Very Poor” range. In 2022, Mumbai had 18 days with a “Poor” AQI in November and December, and almost every day between December 4 and 18. In contrast, the city did not experience any “Very Poor” AQI days in 2020, but had eight such days in 2021. According to SAFAR, AQI levels between 0-50 are considered “Good,” 51-100 are “Satisfactory,” 101-200 are “Moderate,” 201-300 are “Poor,” 301-400 are “Very Poor,” and above 400 are “Severe.”
On Saturday, Mumbai’s air quality remained “poor” with an AQI of 203, continuing the trend from last week. The drop in temperature has resulted in a decrease in air quality in the city, which has had worse AQI than Delhi at least twice in the past week. Other cities in India also have poor air quality, with Pune at 181, Chennai at 178, Hyderabad at 232, Kolkata at 265, Bengaluru at 102, Ahmedabad at 130, and Delhi at 311. Delhi’s AQI is currently “very poor.”
According to SAFAR, the combination of stagnant winds, the drop in temperature, and suspended pollutants mixing with moisture in the atmosphere is causing haze in Mumbai. The air quality in the city is expected to worsen as the temperature continues to decrease. The pollutant PM 2.5 and PM 10 concentrations are currently at 130 and 203, respectively. The AQI in different areas of Mumbai include Navy Nagar and Colaba at 236, Malad at 212, Worli at 132, Sion at 165, Thane and Pimpleshwar Mandir at 127, and Nerul and Navi Mumbai at 239.
Mumbai’s Air Pollution Crisis Continues : Hazardous Air Quality Levels
Latest from Health
Missouri’s Whooping Cough Cases Surge 10-Fold; Flu Cases Exceed 3,000 Amid Rising Heart Attack Risks
The convergence of respiratory illnesses – COVID-19, influenza, RSV, and the common cold – has created complex challenges for public health systems this winter season. Missouri health officials report a concerning seven-fold
FDA Ends Tirzepatide Shortage, Orders Compounded Versions Phased Out by March 2024
The Food and Drug Administration (FDA) confirmed Thursday that Eli Lilly’s tirzepatide-based medications, Zepbound and Mounjaro, are no longer in shortage. This decision requires compounding pharmacies to cease production of alternative versions
FDA Warns: Librela Linked to 3,600+ Adverse Reactions, Including Seizures and Deaths in Dogs
The Food and Drug Administration’s Center for Veterinary Medicine has issued an urgent warning about Librela, a widely-used injectable medication for dogs with osteoarthritis, following reports of severe adverse effects including deaths.
First Severe U.S. H5N1 Case; California Declares Emergency
The United States faces intensifying challenges in its battle against avian influenza A(H5N1) as federal health officials confirm the nation’s first severe human case in Louisiana, while California declares a state of
Russia to Offer Free mRNA Cancer Vaccine for Patients Starting 2025 Amid Tumor Suppression Breakthroughs
Russia’s Ministry of Health has announced the development of an mRNA-based cancer vaccine, scheduled for free distribution to patients beginning in early 2025. This development emerges amid global efforts to harness mRNA
EPA Bans TCE and PCE, Impacting Industrial Chemical Use Nationwide
The U.S. Environmental Protection Agency (EPA) has enacted a comprehensive ban on two prevalent cancer-causing chemicals – trichloroethylene (TCE) and perchloroethylene (PCE) – marking the end of their widespread use in consumer
RFK Jr.’s Lawyer Petitioned FDA to Revoke Polio Vaccine Approval
Aaron Siri, a lawyer helping Robert F. Kennedy Jr., has filed petitions seeking to revoke FDA approval of the polio vaccine and suspend distribution of 13 other vaccines. This development comes as
Stanford’s Skin Cream Vaccine Saves Mice From 6x Lethal Tetanus Dose—A Needle-Free Breakthrough?
In a development that could reshape vaccination methods, Stanford University scientists have designed a tetanus vaccine that can be delivered through the skin in the form of a cream. Published in Nature,
Study Links Ozempic to 4x Higher Risk of Sudden Blindness in Diabetes Patients—Key Facts About Eye Stroke
A new study published on medRxiv reveals that diabetes patients using Ozempic face over twice the risk of developing a rare but serio s eye condition compared to those on other diabetes
H5N1 Bird Flu Jumps to Cows, Hits 140M Poultry, and Mutates Toward Human Pandemic Risk
The H5N1 bird flu virus has reached an alarming new phase of transmission and mutation, creating what health experts warn could become the next global pandemic. With confirmed human cases in the
RSV Cases Surge: 49.8% of Infant Hospitalizations Linked to Virus as New Vaccines Aim to Cut 14,000 Admissions
Rising cases of respiratory syncytial virus (RSV) across North America have prompted health authorities to accelerate the deployment of new preventive measures, as data shows concerning infection rates, particularly among infants and
Louisiana Confirms First H5N1 Bird Flu Case Amid U.S. Outbreaks in 845 Dairy Herds and 120M Poultry
The Louisiana Department of Health (LDH) announced Friday the state’s first presumptive human case of H5N1 bird flu. A resident of southwestern Louisiana is currently hospitalized and had exposure to sick and
Colon Cancer Risk Doubles in Millennials as Processed Foods, Seed Oils, and Omega Imbalance Fuel Tumor Growth
A recent study by researchers at the University of South Florida and Tampa General Hospital Cancer Institute reveals alarming connections between dietary choices and colon cancer risk. The research, published in the
FDA Recalls 7,107 Duloxetine Bottles Due to Cancer-Linked N-Nitroso Contamination Risk
Rising Pharmaceuticals has initiated a nationwide recall of 7,107 bottles of duloxetine after discovering contamination with N-nitroso-duloxetine, a chemical compound linked to cancer risks. The recall, classified as Class II by the
Disease X Outbreak in Congo: 375 Cases, 79 Deaths, Most Victims Under 18 as Scientists Scramble for Answers
A severe outbreak of an unidentified illness, dubbed “Disease X,” has infected 375 people and caused 79 deaths in the Democratic Republic of Congo’s (DRC) Kwango Province since October 24, 2024. The